Published by:

Cancer Intelligence

EBCC

The 6th European Breast Cancer Conference

Berlin, 15-19 April 2008

Watch Press Conferences from EBCC 6

 

Official EBCC 6 Press Conference - 16th April 2008

Adobe Flash player is required to view ecancer.tv

get flash player

Dr. Sibylle Loibl

ecancer.tv

Dr. Sibylle Loibl: Pregnant patients lose out in breast cancer treatment.
View slides

Dr. David Martinez-Cecila

ecancer.tv

Dr. David Martinez-Cecila: MRI before surgery leads to better-adapted treatment.
View slides

Dr. Evandro de Azambuja

ecancer.tv

Dr. Evandro de Azambuja: Obese women disadvantaged in both treatment and diagnosis.
View slides

Dr. Elisabetta Rapiti

ecancer.tv

Dr. Elisabetta Rapiti: Obese women disadvantaged in both treatment and diagnosis.
View slides

Official EBCC 6 Press Conference - 17 April 2008

Adobe Flash player is required to view ecancer.tv

get flash player

Dr. Alain Monnier

ecancer.tv

Dr. Alain Monnier: New research shows no link between aromatase inhibitors and cardiovascular problems.
View slides

Professor Gunter von Minckwitz

ecancer.tv

Professor Gunter von Minckwitz: New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.
View slides

Dr. Angel Rodriguez

ecancer.tv

Dr. Angel Rodriguez: New drug shrinks breast cancer tumours significantly in just six weeks; research shows that cancer stem cells can be therapeutic target.
View slides

Official EBCC 6 Press Conference - 18 April 2008

Adobe Flash player is required to view ecancer.tv

get flash player

Mr. Jacques Fracheboud

ecancer.tv

Mr. Jacques Fracheboud: Is an annual mammogram better than a three-yearly one, and should women be screened up to the age of 75?

Professor Roger Blamey

ecancer.tv

Professor Roger Blamey: Is an annual mammogram better than a three-yearly one, and should women be screened up to the age of 75?
View slides

Ms Jill Hervik

ecancer.tv

Ms Jill Hervik: Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen.
View slides

Professor Michael Untch

ecancer.tv

Professor Michael Untch: Combining trastuzumab with neoadjuvant chemotherapy before surgery; surprising new data on safety and efficacy.
View slides

ECCO and ESMO join forces

Adobe Flash player is required to view ecancer.tv

get flash player

ECCO and ESMO join forces

ecancer.tv

ECCO and ESMO join forces: Michel Ballieu, CEO of ECCO, and Åge Schultz, Executive Director of ESMO, discuss the new collaboration.

 

Watch further interviews here.

For the official EBCC 6 press releases please visit ECCO.